Scale-up of a novel vital signs alert device to improve maternity care in Sierra Leone: a mixed methods evaluation of adoption.


Journal

Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380

Informations de publication

Date de publication:
06 Jan 2023
Historique:
received: 06 07 2022
accepted: 13 12 2022
entrez: 7 1 2023
pubmed: 8 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

The CRADLE (Community blood pressure monitoring in Rural Africa: Detection of underLying pre-Eclampsia) Vital Signs Alert device-designed specifically to improve maternity care in low resource settings-had varying impact when trialled in different countries. To better understand the contextual factors that may contribute to this variation, this study retrospectively evaluated the adoption of CRADLE, during scale-up in Sierra Leone. This was a mixed methods study. A quantitative indicator of adoption (the proportion of facilities trained per district) was calculated from existing training records, then focus groups were held with 'CRADLE Champions' in each district (n = 32), to explore adoption qualitatively. Template Analysis was used to deductively interpret qualitative data, guided by the NASSS (non-adoption, abandonment, scale-up, spread, sustainability) Framework. Substantial but non-significant variation was found in the proportion of facilities trained in each district (range 59-90%) [X Complexity related to the technology and the organisational context were found to influence the adoption of CRADLE in Sierra Leone, with substantial inter-district variation. These findings emphasise the importance of gaining an in-depth understanding of the specific system and context in which a new healthcare technology is being implemented. This study has implications for the ongoing scale-up of CRADLE, and for those implementing or evaluating other health technologies in similar contexts. Many women die during pregnancy and childbirth from causes that could be prevented, and the vast majority of these deaths occur in low-resource settings. The ‘CRADLE Vital Signs Alert’ is a medical device that helps identify problems during pregnancy—designed specifically for healthcare professionals in low-resource settings. However, for unknown reasons, the device appears to have varying impact according to the country or setting in which it is used. This study aimed to explore in depth whether, and why, healthcare professionals in Sierra Leone adopted the device and engaged in training (or not). Between March 2020 and January 2021, the CRADLE device and training package was disseminated across 8 districts in Sierra Leone. This relied on a few healthcare workers (nominated ‘CRADLE Champions’) to voluntarily distribute the devices and training in their local areas. Group discussions were held with CRADLE Champions in each district after the rollout to gather their feedback. In addition, the proportion of facilities trained in each district was recorded. The study found differences in how well the device and training was adopted in each district. Common challenges reported across districts related to technological difficulties (such as issues charging the devices) and organisational barriers (such as high levels of staff turnover at facilities). These findings will help to inform future rollout of the CRADLE device and training in Sierra Leone and highlight factors that may need to be considered by those implementing other health technologies in similar settings.

Sections du résumé

BACKGROUND BACKGROUND
The CRADLE (Community blood pressure monitoring in Rural Africa: Detection of underLying pre-Eclampsia) Vital Signs Alert device-designed specifically to improve maternity care in low resource settings-had varying impact when trialled in different countries. To better understand the contextual factors that may contribute to this variation, this study retrospectively evaluated the adoption of CRADLE, during scale-up in Sierra Leone.
METHODS METHODS
This was a mixed methods study. A quantitative indicator of adoption (the proportion of facilities trained per district) was calculated from existing training records, then focus groups were held with 'CRADLE Champions' in each district (n = 32), to explore adoption qualitatively. Template Analysis was used to deductively interpret qualitative data, guided by the NASSS (non-adoption, abandonment, scale-up, spread, sustainability) Framework.
FINDINGS RESULTS
Substantial but non-significant variation was found in the proportion of facilities trained in each district (range 59-90%) [X
CONCLUSIONS CONCLUSIONS
Complexity related to the technology and the organisational context were found to influence the adoption of CRADLE in Sierra Leone, with substantial inter-district variation. These findings emphasise the importance of gaining an in-depth understanding of the specific system and context in which a new healthcare technology is being implemented. This study has implications for the ongoing scale-up of CRADLE, and for those implementing or evaluating other health technologies in similar contexts.
Many women die during pregnancy and childbirth from causes that could be prevented, and the vast majority of these deaths occur in low-resource settings. The ‘CRADLE Vital Signs Alert’ is a medical device that helps identify problems during pregnancy—designed specifically for healthcare professionals in low-resource settings. However, for unknown reasons, the device appears to have varying impact according to the country or setting in which it is used. This study aimed to explore in depth whether, and why, healthcare professionals in Sierra Leone adopted the device and engaged in training (or not). Between March 2020 and January 2021, the CRADLE device and training package was disseminated across 8 districts in Sierra Leone. This relied on a few healthcare workers (nominated ‘CRADLE Champions’) to voluntarily distribute the devices and training in their local areas. Group discussions were held with CRADLE Champions in each district after the rollout to gather their feedback. In addition, the proportion of facilities trained in each district was recorded. The study found differences in how well the device and training was adopted in each district. Common challenges reported across districts related to technological difficulties (such as issues charging the devices) and organisational barriers (such as high levels of staff turnover at facilities). These findings will help to inform future rollout of the CRADLE device and training in Sierra Leone and highlight factors that may need to be considered by those implementing other health technologies in similar settings.

Autres résumés

Type: plain-language-summary (eng)
Many women die during pregnancy and childbirth from causes that could be prevented, and the vast majority of these deaths occur in low-resource settings. The ‘CRADLE Vital Signs Alert’ is a medical device that helps identify problems during pregnancy—designed specifically for healthcare professionals in low-resource settings. However, for unknown reasons, the device appears to have varying impact according to the country or setting in which it is used. This study aimed to explore in depth whether, and why, healthcare professionals in Sierra Leone adopted the device and engaged in training (or not). Between March 2020 and January 2021, the CRADLE device and training package was disseminated across 8 districts in Sierra Leone. This relied on a few healthcare workers (nominated ‘CRADLE Champions’) to voluntarily distribute the devices and training in their local areas. Group discussions were held with CRADLE Champions in each district after the rollout to gather their feedback. In addition, the proportion of facilities trained in each district was recorded. The study found differences in how well the device and training was adopted in each district. Common challenges reported across districts related to technological difficulties (such as issues charging the devices) and organisational barriers (such as high levels of staff turnover at facilities). These findings will help to inform future rollout of the CRADLE device and training in Sierra Leone and highlight factors that may need to be considered by those implementing other health technologies in similar settings.

Identifiants

pubmed: 36609353
doi: 10.1186/s12978-022-01551-2
pii: 10.1186/s12978-022-01551-2
pmc: PMC9817393
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© 2022. The Author(s).

Références

Implement Sci. 2019 Apr 18;14(1):38
pubmed: 30999963
BMJ Innov. 2018 Oct;4(4):192-198
pubmed: 30319784
Reprod Health. 2018 Jan 05;15(1):5
pubmed: 29304812
Lancet Glob Health. 2019 Mar;7(3):e347-e356
pubmed: 30784635
Global Health. 2019 Jan 22;15(1):8
pubmed: 30670026
BMC Med Res Methodol. 2020 Nov 30;20(1):287
pubmed: 33256625
BMC Public Health. 2019 Sep 11;19(1):1247
pubmed: 31510975
J Glob Health. 2018 Dec;8(2):020601
pubmed: 30023054
Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
Implement Sci. 2016 Jan 29;11:12
pubmed: 26821910
J Med Internet Res. 2011 Dec 28;13(4):e124
pubmed: 22204896
Health Res Policy Syst. 2017 Jul 12;15(Suppl 1):49
pubmed: 28722561
PLoS One. 2020 Sep 15;15(9):e0239234
pubmed: 32931509
PLoS One. 2018 Feb 20;13(2):e0188280
pubmed: 29462152
BMC Pregnancy Childbirth. 2018 Apr 27;18(1):115
pubmed: 29703254
BMC Med. 2019 Dec 30;17(1):233
pubmed: 31888718
Global Health. 2018 Oct 22;14(1):100
pubmed: 30348183
BJOG. 2015 Jan;122(2):268-75
pubmed: 25546050
PLoS One. 2016 Feb 22;11(2):e0148729
pubmed: 26901161
Front Public Health. 2019 Mar 29;7:64
pubmed: 30984733
JMIR Res Protoc. 2020 May 13;9(5):e16861
pubmed: 32401224
JMIR Med Inform. 2022 Feb 3;10(2):e30040
pubmed: 35113026
J Med Internet Res. 2017 Nov 01;19(11):e367
pubmed: 29092808
J Eval Clin Pract. 2019 Jun;25(3):373-380
pubmed: 30632246
Lancet. 2006 Apr 1;367(9516):1066-1074
pubmed: 16581405
Lancet. 2008 Sep 13;372(9642):962-71
pubmed: 18790319

Auteurs

Sophie Bright (S)

School of Health and Related Research, University of Sheffield, Sheffield, England.

Francis Moses (F)

Reproductive Health and Family Planning, MoHS, Freetown, Sierra Leone. franqoline@gmail.com.

Alex Ridout (A)

King's College London (KCL), London, England.

Betty Sam (B)

Welbodi Partnership, Freetown, Sierra Leone.

Mariama Momoh (M)

Ministry of Health and Sanitation (MoHS), Freetown, Sierra Leone.

Venetia Goodhart (V)

Welbodi Partnership, Freetown, Sierra Leone.

Francis Smart (F)

Planning and Information, MoHS, Freetown, Sierra Leone.

Margaret Mannah (M)

Quality Management Programme, MoHS, Freetown, Sierra Leone.

Sattu Issa (S)

Reproductive Health and Family Planning, MoHS, Freetown, Sierra Leone.

Simren Herm-Singh (S)

Welbodi Partnership, Freetown, Sierra Leone.

Fiona Reid (F)

Department of Population Health Sciences, KCL, London, England.

Paul T Seed (PT)

Department of Women and Children's Health, KCL, London, England.

James Bunn (J)

World Health Organization, Freetown, Sierra Leone.

Andrew Shennan (A)

Department of Women and Children's Health, KCL, London, England.

Katrin Augustin (K)

School of Population Health and Environmental Sciences, KCL, London, England.

Jane Sandall (J)

Women's Health Academic Centre, KCL, London, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH